Sort
16,300 grants matching “fatty liver disease”
Renal Disposition in NASH
$482,102Nathan J Cherrington · University Of Arizona · R01 · FY2023 · ES
Renal Disposition in NASH
$482,102Nathan J Cherrington · University Of Arizona · R01 · FY2022 · ES
Decreased Fat Oxidation - Metabolic Inflexibility in African-American Women
$482,089James Delany · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · DK
Diet and Gene Effects on Atherosclerosis and CVD Risk
$482,053Michael C. Mahaney · Texas Biomedical Research Institute · P01 · FY2010 · HL
LIPOPROTEIN AND HYPERTENSION QTL CANDIDATE GENES
$482,053Laura A Cox · Texas Biomedical Research Institute · P01 · FY2010 · HL
Project2: Impact of adipose-tissue derived FGF21 on immunometabolic control of aging
$482,039Philipp E Scherer · Yale University · P01 · FY2025 · AG
Project 1 - Dixit
$482,039Vishwa Deep Dixit · Yale University · P01 · FY2025 · AG
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma (NOURISH OK)
$482,021Marianna Wetherill · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · DK
Aberrant BCAA utilization in alcohol-induced metabolic dysregulation
$482,000Heejin Jun · Texas Tech University · R15 · FY2023 · AA
A lipid-induced RNA-binding protein in atherosclerosis
$481,964Ebru Erbay · Cedars-Sinai Medical Center · R01 · FY2020 · HL
Lipid Aldehyde and Ethanol Induced Liver Damage
$481,789Dennis Petersen · University Of Colorado Denver · R37 · FY2017 · AA
Stratification of Non-alcoholic Fatty Liver Disease using the SAFE Score
$481,685W. Ray Kim · Stanford University · R01 · FY2021 · DK
Effect of Alcohol on Obesity Related Liver Disease
$481,606Arun J Sanyal · Virginia Commonwealth University · R01 · FY2014 · AA
Inhibition of EGF Receptor Prevents and Reverses Non-Alcoholic Fatty Liver Disease
$481,570George K Michalopoulos · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
$481,473Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2024 · CA
Regulation of Cellular Cholesterol Homeostasis
$481,283Peter John Espenshade · Johns Hopkins University · R01 · FY2019 · HL
Molecular Biophysics of Mitochondrial Membranes
$481,270Yuriy Kirichok · University Of California, San Francisco · R35 · FY2022 · GM
Regulation of Sex Differences in Liver Metabolism
$481,222David J Waxman · Boston University (Charles River Campus) · R01 · FY2017 · DK
Regulation of Glycogen in Health and Disease
$481,198Alan R. Saltiel · University Of California, San Diego · R01 · FY2021 · DK
Identification of metabolic regulators of glycerolipid synthesis and storage
$481,105Kivanc Birsoy · Rockefeller University · R01 · FY2023 · DK
Mechanisms by which time-restricted feeding (TRF) delays the onset of age-related declines in health, cognition, and circadian rhythms
$481,000Amandine H. Chaix · Salk Institute For Biological Studies · R01 · FY2020 · AG
Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLD
$480,908David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · DK
Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLD
$480,908David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · DK
ADIPOSE TISSUE MACROPHAGE PHENOTYPE AND FUNCTION
$480,830Anthony W Ferrante · Columbia University Health Sciences · R01 · FY2019 · DK
ADIPOSE TISSUE MACROPHAGE PHENOTYPE AND FUNCTION
$480,830Anthony W Ferrante · Columbia University Health Sciences · R01 · FY2017 · DK